0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Bipolar Disorder (Manic Depression) - Epidemiology Forecast
Published Date: March 2019
|
Report Code: DELV-Epid-433
Home | Market Reports | Health | Mental Health | Depression
Bipolar Disorder Epidemiology Forecast to 2028

Bipolar Disorder (Manic Depression) - Epidemiology Forecast

Code: DELV-Epid-433
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Bipolar Disorder (Manic Depression) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Bipolar Disorder (Manic Depression) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Bipolar Disorder (Manic Depression) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Bipolar Disorder (Manic Depression) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Bipolar Disorder (Manic Depression) outlook. It also includes the explanation of changing trends of epidemiology outlining the Bipolar Disorder (Manic Depression) scenario.

Bipolar Disorder (Manic Depression) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Bipolar Disorder (Manic Depression) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Bipolar Disorder (Manic Depression) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Bipolar Disorder (Manic Depression) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Bipolar Disorder (Manic Depression)

Key assessments
• Patient Segmentation in Bipolar Disorder (Manic Depression)
• Bipolar Disorder (Manic Depression) Risk & Burden
• Factors driving growth in a specific Bipolar Disorder (Manic Depression) patient population

1. Report Introduction
2. Bipolar Disorder (Manic Depression) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Bipolar Disorder (Manic Depression) in 2016
2.2. Patient Share Distribution of Bipolar Disorder (Manic Depression) in 2028
3. Disease Background and Overview: Bipolar Disorder (Manic Depression)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Bipolar Disorder (Manic Depression) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Bipolar Disorder (Manic Depression) in 7MM – By Countries
5. Epidemiology of Bipolar Disorder (Manic Depression) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
5.1.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) *
5.1.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression) *
5.1.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
5.4.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) *
5.4.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression) *
5.4.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
5.5.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) *
5.5.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression) *
5.5.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
5.6.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) *
5.6.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression) *
5.6.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
5.7.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) *
5.7.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression) *
5.7.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
5.8.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) *
5.8.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression) *
5.8.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
5.9.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) *
5.9.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression) *
5.9.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
6. Unmet Needs of the Bipolar Disorder (Manic Depression)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

LIST OF TABLES :

Table 1: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM
Table 2: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028) *
Table 14: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)

LIST OF FIGURES :

Figure 1: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)

 

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global Vortioxetine Market Insights and Forecast to 2028
Global Vortioxetine Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-24S7624
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Depression Treatment Therapy Market Insights Forecast to 2028
Global Depression Treatment Therapy Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-4N2473
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

Global and United States Paroxetine Market Report Forecast 2022 2028
Global and United States Paroxetine Market Report & Forecast 2022-2028

It has also been used in the treatment of hot flashes and night sweats associated with menopause.Market Analysis and Insights Global and United States Paroxetine MarketThis report focuses on global and United States Paroxetine market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Paroxetine market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-7E10691
Tue Apr 05 00:00:00 UTC 2022

Add to Cart

Global Anxiety and Depression Treatment Market Research Report 2022
Global Anxiety and Depression Treatment Market Research Report 2022

Market Analysis and Insights Global Anxiety and Depression Treatment MarketThe global Anxiety and Depression Treatment market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Anxiety Drugs accounting for of the Anxiety and Depression Treatment global market in 2021 is projected to value US million by 2028 growing at a revised CAGR from 2022 to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-11B10565
Tue Apr 05 00:00:00 UTC 2022

Add to Cart